| The emerging role of lncRNAs in the regulation of cancer stem cells |
39 |
| Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma |
28 |
| Tumor-associated macrophages: role in cancer development and therapeutic implications |
27 |
| Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer |
24 |
| Recent advances in the clinical development of immune checkpoint blockade therapy |
20 |
| The emerging role of noncoding RNAs in colorectal cancer chemoresistance |
17 |
| Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance |
16 |
| Leptin-induced signaling pathways in cancer cell migration and invasion |
16 |
| CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer |
15 |
| Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD) |
15 |
| SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines |
14 |
| Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells |
14 |
| Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells |
14 |
| MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives |
13 |
| Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis |
13 |
| The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications |
12 |
| CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer |
11 |
| Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis |
11 |
| Epigenetics of lung cancer: a translational perspective |
11 |
| Role of beta-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma |
10 |
| Emerging ways to treat breast cancer: will promises be met? |
10 |
| Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target |
10 |
| Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer |
10 |
| LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients |
9 |
| Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges |
9 |
| Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells |
9 |
| Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis |
9 |
| Cell-free DNA in cancer: current insights |
8 |
| Interplay between NRF E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression |
8 |
| Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN |
8 |
| Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition |
8 |
| Memory CD4(+) T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells |
8 |
| A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells |
7 |
| Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma-MCT1 as potential target in diffuse large B cell lymphoma |
7 |
| Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells |
7 |
| CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification |
7 |
| Molecular profiling of anastatic cancer cells: potential role of the nuclear export pathway |
7 |
| Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells |
7 |
| The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges |
7 |
| Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells |
6 |
| Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis |
6 |
| Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy |
6 |
| Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma |
6 |
| Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation |
6 |
| TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms |
6 |
| Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells |
6 |
| The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells |
6 |
| Inhibition of CBP/beta-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells |
6 |
| Glycogen synthase kinase-3 beta mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion |
6 |
| Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report |
6 |
